Elbit Imaging Ltd. (EMITF)
USD 1.2
(0.0%)
USD 1.2
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.11 Million ILS | -17.39% |
| 2022 | 1.35 Million ILS | 0.3% |
| 2021 | 1.34 Million ILS | -82.18% |
| 2020 | 7.56 Million ILS | -97.63% |
| 2019 | 319.49 Million ILS | 1.09% |
| 2018 | 316.05 Million ILS | -72.9% |
| 2017 | 1.16 Billion ILS | -47.29% |
| 2016 | 2.21 Billion ILS | -7.79% |
| 2015 | 2.39 Billion ILS | -18.61% |
| 2014 | 2.94 Billion ILS | -40.72% |
| 2013 | 4.97 Billion ILS | -12.34% |
| 2012 | 5.67 Billion ILS | -35.77% |
| 2011 | 8.83 Billion ILS | 3.6% |
| 2010 | 8.52 Billion ILS | 17.94% |
| 2009 | 7.22 Billion ILS | 15.59% |
| 2008 | 6.25 Billion ILS | 19.53% |
| 2007 | 5.23 Billion ILS | 33.62% |
| 2006 | 3.91 Billion ILS | 44.09% |
| 2005 | 2.71 Billion ILS | -17.44% |
| 2004 | 3.29 Billion ILS | -19.44% |
| 2003 | 4.08 Billion ILS | -4.41% |
| 2002 | 4.27 Billion ILS | 35.3% |
| 2001 | 3.15 Billion ILS | 39.62% |
| 2000 | 2.26 Billion ILS | 44.12% |
| 1999 | 1.56 Billion ILS | 30.39% |
| 1998 | 1.2 Billion ILS | 25.24% |
| 1997 | 961.35 Million ILS | 13.62% |
| 1996 | 846.1 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 929 Thousand ILS | 0.0% |
| 2024 Q1 | 929 Thousand ILS | -16.76% |
| 2023 Q3 | 498 Thousand ILS | -92.49% |
| 2023 Q2 | 6.63 Million ILS | 10.28% |
| 2023 FY | 1.11 Million ILS | -17.39% |
| 2023 Q1 | 6.01 Million ILS | 345.15% |
| 2023 Q4 | 1.11 Million ILS | 124.1% |
| 2022 Q1 | 969 Thousand ILS | -28.06% |
| 2022 Q3 | 733 Thousand ILS | -56.29% |
| 2022 Q2 | 1.67 Million ILS | 73.07% |
| 2022 Q4 | 1.35 Million ILS | 84.31% |
| 2022 FY | 1.35 Million ILS | 0.3% |
| 2021 Q3 | 867 Thousand ILS | -80.26% |
| 2021 Q4 | 1.34 Million ILS | 55.36% |
| 2021 Q2 | 4.39 Million ILS | 12.27% |
| 2021 FY | 1.34 Million ILS | -82.18% |
| 2021 Q1 | 3.91 Million ILS | -48.24% |
| 2020 Q4 | 7.56 Million ILS | 5.96% |
| 2020 Q1 | 9.7 Million ILS | -96.96% |
| 2020 Q2 | 9.7 Million ILS | 0.0% |
| 2020 Q3 | 7.13 Million ILS | -26.51% |
| 2020 FY | 7.56 Million ILS | -97.63% |
| 2019 Q1 | - ILS | -100.0% |
| 2019 FY | 319.49 Million ILS | 1.09% |
| 2019 Q3 | 314.03 Million ILS | 0.0% |
| 2019 Q4 | 319.49 Million ILS | 1.74% |
| 2018 Q4 | 316.05 Million ILS | 0.0% |
| 2018 Q1 | 830.3 Million ILS | -28.8% |
| 2018 Q3 | - ILS | -100.0% |
| 2018 Q2 | 830.3 Million ILS | 0.0% |
| 2018 FY | 316.05 Million ILS | -72.9% |
| 2017 Q4 | 1.16 Billion ILS | 0.0% |
| 2017 FY | 1.16 Billion ILS | -47.29% |
| 2017 Q1 | 1.67 Billion ILS | -24.17% |
| 2017 Q2 | 1.82 Billion ILS | 8.92% |
| 2017 Q3 | 1.16 Billion ILS | -36.19% |
| 2016 FY | 2.21 Billion ILS | -7.79% |
| 2016 Q4 | 2.21 Billion ILS | -6.65% |
| 2016 Q3 | 2.37 Billion ILS | -2.27% |
| 2016 Q2 | 2.42 Billion ILS | -1.72% |
| 2016 Q1 | 2.46 Billion ILS | 225.11% |
| 2015 Q1 | 2.87 Billion ILS | 254.57% |
| 2015 Q2 | 2.53 Billion ILS | -12.0% |
| 2015 Q3 | 2.47 Billion ILS | -2.34% |
| 2015 Q4 | 758.96 Million ILS | -69.34% |
| 2015 FY | 2.39 Billion ILS | -18.61% |
| 2014 Q2 | 3.16 Billion ILS | 0.13% |
| 2014 FY | 2.94 Billion ILS | -40.72% |
| 2014 Q4 | 812.26 Million ILS | -73.62% |
| 2014 Q3 | 3.07 Billion ILS | -2.69% |
| 2014 Q1 | 3.16 Billion ILS | -36.45% |
| 2013 FY | 4.97 Billion ILS | -12.34% |
| 2013 Q4 | 4.97 Billion ILS | 0.22% |
| 2013 Q3 | 4.96 Billion ILS | -4.46% |
| 2013 Q2 | 5.19 Billion ILS | 0.92% |
| 2013 Q1 | 5.14 Billion ILS | -9.29% |
| 2012 Q1 | 8.53 Billion ILS | -3.36% |
| 2012 Q4 | 5.67 Billion ILS | -7.23% |
| 2012 Q2 | 6.78 Billion ILS | -20.55% |
| 2012 FY | 5.67 Billion ILS | -35.77% |
| 2012 Q3 | 6.11 Billion ILS | -9.81% |
| 2011 Q2 | 8.96 Billion ILS | -0.76% |
| 2011 Q1 | 9.03 Billion ILS | 5.97% |
| 2011 FY | 8.83 Billion ILS | 3.6% |
| 2011 Q4 | 8.83 Billion ILS | -1.77% |
| 2011 Q3 | 8.99 Billion ILS | 0.29% |
| 2010 FY | 8.52 Billion ILS | 17.94% |
| 2010 Q2 | 9.21 Billion ILS | 24.27% |
| 2010 Q3 | 9.22 Billion ILS | 0.18% |
| 2010 Q1 | 7.41 Billion ILS | 2.53% |
| 2010 Q4 | 8.52 Billion ILS | -7.61% |
| 2009 FY | 7.22 Billion ILS | 15.59% |
| 2009 Q3 | 7.11 Billion ILS | 3.25% |
| 2009 Q2 | 6.89 Billion ILS | 2.91% |
| 2009 Q1 | 6.69 Billion ILS | 7.06% |
| 2009 Q4 | 7.22 Billion ILS | 1.6% |
| 2008 FY | 6.25 Billion ILS | 19.53% |
| 2008 Q2 | 6.21 Billion ILS | 0.86% |
| 2008 Q1 | 6.16 Billion ILS | 17.84% |
| 2008 Q3 | 6.18 Billion ILS | -0.47% |
| 2008 Q4 | 6.25 Billion ILS | 1.04% |
| 2007 Q4 | 5.23 Billion ILS | -7.46% |
| 2007 Q3 | 5.65 Billion ILS | 13.87% |
| 2007 Q2 | 4.96 Billion ILS | 22.43% |
| 2007 Q1 | 4.05 Billion ILS | 3.58% |
| 2007 FY | 5.23 Billion ILS | 33.62% |
| 2006 Q3 | 3.95 Billion ILS | 16.64% |
| 2006 Q4 | 3.91 Billion ILS | -1.03% |
| 2006 Q1 | 3.49 Billion ILS | 28.77% |
| 2006 FY | 3.91 Billion ILS | 44.09% |
| 2006 Q2 | 3.39 Billion ILS | -3.07% |
| 2005 Q2 | 3.38 Billion ILS | 1.35% |
| 2005 Q3 | 2.75 Billion ILS | -18.4% |
| 2005 FY | 2.71 Billion ILS | -17.44% |
| 2005 Q4 | 2.71 Billion ILS | -1.51% |
| 2005 Q1 | 3.33 Billion ILS | 1.35% |
| 2004 Q2 | 4.27 Billion ILS | 0.0% |
| 2004 Q3 | 3.19 Billion ILS | -25.31% |
| 2004 FY | 3.29 Billion ILS | -19.44% |
| 2004 Q4 | 3.29 Billion ILS | 3.15% |
| 2003 Q3 | 3.89 Billion ILS | -0.77% |
| 2003 Q4 | 4.08 Billion ILS | 4.79% |
| 2003 Q1 | 4.26 Billion ILS | -0.27% |
| 2003 Q2 | 3.92 Billion ILS | -7.82% |
| 2003 FY | 4.08 Billion ILS | -4.41% |
| 2002 Q1 | 3.82 Billion ILS | 21.16% |
| 2002 FY | 4.27 Billion ILS | 35.3% |
| 2002 Q2 | 4.18 Billion ILS | 9.3% |
| 2002 Q4 | 4.27 Billion ILS | 0.04% |
| 2002 Q3 | 4.27 Billion ILS | 2.13% |
| 2001 Q1 | 2.77 Billion ILS | 22.66% |
| 2001 Q4 | 3.15 Billion ILS | 4.29% |
| 2001 FY | 3.15 Billion ILS | 39.62% |
| 2001 Q3 | 3.02 Billion ILS | 0.0% |
| 2000 FY | 2.26 Billion ILS | 44.12% |
| 2000 Q1 | 1.54 Billion ILS | -1.59% |
| 2000 Q4 | 2.26 Billion ILS | 3.67% |
| 2000 Q3 | 2.18 Billion ILS | 34.47% |
| 2000 Q2 | 1.62 Billion ILS | 5.05% |
| 1999 FY | 1.56 Billion ILS | 30.39% |
| 1999 Q4 | 1.56 Billion ILS | 0.0% |
| 1998 FY | 1.2 Billion ILS | 25.24% |
| 1998 Q4 | 1.2 Billion ILS | 0.0% |
| 1997 FY | 961.35 Million ILS | 13.62% |
| 1997 Q4 | 961.35 Million ILS | 0.0% |
| 1996 Q4 | 846.1 Million ILS | 0.0% |
| 1996 FY | 846.1 Million ILS | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | 94.382% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 47.309% |
| Össur hf. | 688.8 Million USD | 99.838% |
| QHSLab, Inc. | 2.05 Million USD | 45.748% |
| Wellstar International, Inc. | 55.99 Million USD | 98.007% |
| Össur hf. | 688.8 Million USD | 99.838% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | 62.148% |
| Aurora Spine Corporation | 6.65 Million USD | 83.227% |
| BrainsWay Ltd. | 15.31 Million USD | 92.713% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 93.286% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 97.566% |
| Vivos Inc. | 245 Thousand USD | -355.503% |
| Kelyniam Global, Inc. | 1.01 Million USD | -10.175% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -304.914% |
| Zecotek Photonics Inc. | 5.86 Million USD | 80.984% |
| Avitar, Inc. | 11.59 Million USD | 90.374% |
| Nanomix Corporation | 14.81 Million USD | 92.467% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 93.06% |
| Theraclion SA | 13.01 Million EUR | 91.426% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | 44.916% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 69.181% |
| Lombard Medical, Inc. | 53.79 Million USD | 97.925% |
| ALR Technologies Inc. | 24.5 Million USD | 95.446% |
| Stratec SE | 271.97 Million USD | 99.59% |
| Vycor Medical, Inc. | 4.31 Million USD | 74.153% |
| Heart Tronics, Inc. | 1.09 Million USD | -1.937% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.955% |
| VMS Rehab Systems, Inc. | 201.36 USD | -554131.228% |
| NewCardio, Inc. | 6.01 Million USD | 81.439% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 79.616% |
| Ingen Technologies, Inc. | 5.7 Million USD | 80.454% |
| Odyssey Group International, Inc. | 6.61 Million USD | 83.121% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 54.445% |
| Wellness Center USA, Inc. | 5.12 Million USD | 78.221% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 98.299% |
| IR-Med Inc. | 634 Thousand USD | -76.025% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 79.622% |
| Polarean Imaging plc | 2.58 Million USD | 56.753% |
| United American Healthcare Corporation | 119 Thousand USD | -837.815% |
| ECGI Holdings, Inc. | 11.94 Million USD | 90.654% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 52.688% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 15.709% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 22.84% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -64.695% |
| Urologix, Inc. | 12.64 Million USD | 91.174% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 79.318% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 86.843% |
| SS Innovations International, Inc. | 11.18 Million USD | 90.019% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -112.415% |
| Smith & Nephew plc | 4.76 Billion USD | 99.977% |
| NIOX Group Plc | 9.8 Million USD | 88.615% |
| Fuse Medical, Inc. | 15.11 Million USD | 92.614% |
| Broncus Holding Corporation | 10.43 Million USD | 89.302% |
| Brain Scientific Inc. | 7.42 Million USD | 84.973% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 96.699% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -40.54% |